Amount | Holding |
---|---|
6.39% | Catalent, Inc |
5.92% | Bio-Techne Corporation |
5.85% | Neurocrine Biosciences, Inc |
5.61% | Alexion Pharmaceuticals, Inc |
5.56% | Vertex Pharmaceuticals Incorporated |
4.87% | Amgen Inc |
4.62% | Gilead Sciences, Inc |
4.27% | Biogen Inc |
3.58% | Repligen Corporation |
3.55% | Emergent BioSolutions Inc |